Skip to contentOrbiMed Capital GP VI LLC — Disc Medicine, Inc. insider: 110 transactions · InsiderLensOrbiMed Capital GP VI LLC
- Director at Turnstone Biologics Corp. · on record since Jul 24, 2023
- 10% owner at Turnstone Biologics Corp. · on record since Jul 24, 2023
- 10% owner at SteadyMed Ltd. · on record since Aug 12, 2016
- Director at COMPEX TECHNOLOGIES INC · on record since Apr 11, 2025
- 10% owner at COMPEX TECHNOLOGIES INC · on record since Apr 11, 2025
- 10% owner at NeuroPace Inc · on record since Apr 26, 2021
- 10% owner at ACETO CORP · on record since Apr 9, 2026
- Director at INVERNESS MEDICAL INNOVATIONS INC · on record since Apr 16, 2026
- Director at Prelude Therapeutics Inc · on record since Apr 23, 2026
- 10% owner at Prelude Therapeutics Inc · on record since Apr 23, 2026
- 10% owner at CELL THERAPEUTICS INC · on record since Jun 15, 2017
- Director at Mirna Therapeutics, Inc. · on record since Aug 30, 2017
- Director at ALPINE AIR EXPRESS INC/DE · on record since Jul 26, 2017
- 10% owner at ALPINE AIR EXPRESS INC/DE · on record since Jul 26, 2017
- 10% owner at Kala Pharmaceuticals, Inc. · on record since Jul 19, 2017
- 10% owner at scPharmaceuticals Inc. · on record since Nov 21, 2017
- Director at ACETO CORP · on record since Jan 30, 2018
- 10% owner at ARVINAS, INC. · on record since Sep 26, 2018
- 10% owner at CONSTAR INTERNATIONAL INC · on record since Jul 24, 2018
- 10% owner at Crinetics Pharmaceuticals, Inc. · on record since Jul 17, 2018
- Director at LOGIC DEVICES INC · on record since Oct 25, 2018
- 10% owner at LOGIC DEVICES INC · on record since Oct 25, 2018
- 10% owner at AVEDRO INC · on record since Feb 19, 2019
- Director at Prevail Therapeutics Inc. · on record since Jun 26, 2019
- 10% owner at Prevail Therapeutics Inc. · on record since Jun 26, 2019
- Director at AXONYX INC · on record since Apr 24, 2019
- Director at NextCure, Inc. · on record since May 13, 2019
- 10% owner at NextCure, Inc. · on record since May 13, 2019
- 10% owner at SOUTHWALL TECHNOLOGIES INC /DE/ · on record since Sep 19, 2019
- Director at 89bio, Inc. · on record since Nov 13, 2019
- 10% owner at 89bio, Inc. · on record since Nov 13, 2019
- Director at Oric Pharmaceuticals, Inc. · on record since Apr 28, 2020
- 10% owner at Oric Pharmaceuticals, Inc. · on record since Apr 28, 2020
- 10% owner at CALIFORNIA COASTAL COMMUNITIES INC · on record since Sep 29, 2020
- Director at CALIFORNIA COASTAL COMMUNITIES INC · on record since Sep 24, 2020
- Director at ARS Pharmaceuticals, Inc. · on record since Dec 8, 2020
- 10% owner at ARS Pharmaceuticals, Inc. · on record since Dec 8, 2020
- Director at Edgewise Therapeutics, Inc. · on record since Mar 31, 2021
- 10% owner at Edgewise Therapeutics, Inc. · on record since Mar 31, 2021
- Director at Disc Medicine, Inc. · on record since Feb 10, 2021
- 10% owner at Disc Medicine, Inc. · on record since Feb 10, 2021
- Director at Verona Pharma plc · on record since Jan 5, 2021
- 10% owner at Verona Pharma plc · on record since Jan 5, 2021
Insider trading activity of OrbiMed Capital GP VI LLC
- Transactions on record
- 110
- since Apr 27, 2017
- Open-market buys
- 21
- $45.7M
- Open-market sells
- 51
- $301.7M
- Companies traded
- 21
- last filing Apr 11, 2025
Figures computed from official regulatory filings — methodology.
Companies where OrbiMed Capital GP VI LLC has traded
- COMPEX TECHNOLOGIES INC1 tx · $5.7M · Apr 11, 2025
- Disc Medicine, Inc.28 tx · $19.8M · Mar 21, 2025
- scPharmaceuticals Inc.2 tx · $2M · Aug 15, 2024
- NeuroPace Inc11 tx · $11.3M · Apr 18, 2024
- Edgewise Therapeutics, Inc.2 tx · $6M · Jan 25, 2024
- INVERNESS MEDICAL INNOVATIONS INC6 tx · $1.1M · Sep 14, 2023
- ARS Pharmaceuticals, Inc.1 tx · $3.1M · Aug 31, 2023
- Verona Pharma plc5 tx · $136M · Dec 27, 2022
- SOUTHWALL TECHNOLOGIES INC /DE/4 tx · $107M · Sep 14, 2022
Track record of OrbiMed Capital GP VI LLC
Statistical track record
Free- Open-market buys
- 24
- Last buy
- Aug 13, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of OrbiMed Capital GP VI LLC
Co-insiders of OrbiMed Capital GP VI LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
2 tx · $12M · Apr 22, 2021
Thompson Peter AALPINE AIR EXPRESS INC/DE +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 11, 2025 | Sell | -3,571,428 | 1.59 USD | $5.7M | SEC |
| Mar 21, 2025 | Sell | -13,517 | 54.02 USD | $730.2K | SEC |
| Mar 21, 2025 | Sell | -1,457 | 54.01 USD | $78.7K | SEC |
| Mar 21, 2025 | Sell | -364 | 54.01 USD | $19.7K | SEC |
| Mar 21, 2025 | Sell | -5,228 | 54.02 USD | $282.4K | SEC |
| Mar 21, 2025 | Sell | -3,412 | 54.00 USD | $184.2K | SEC |
| Mar 21, 2025 | Sell | -5,279 | 54.00 USD | $285.1K | SEC |
| Mar 21, 2025 | Sell | -1,320 | 54.00 USD | $71.3K | SEC |
| Mar 21, 2025 | Sell | -941 | 54.01 USD | $50.8K | SEC |
| Mar 21, 2025 | Sell | -20,911 | 54.02 USD | $1.1M | SEC |
| Mar 12, 2025 | Sell | -106,384 | 54.29 USD | $5.8M | SEC |
| Mar 12, 2025 | Sell | -9,222 | 54.01 USD | $498.1K | SEC |
| Mar 12, 2025 | Sell | -3,567 | 54.01 USD | $192.7K | SEC |
| Mar 12, 2025 | Sell | -53 | 55.01 USD | $2.9K | SEC |
| Mar 12, 2025 | Sell | -27,750 | 54.44 USD | $1.5M | SEC |
| Mar 12, 2025 | Sell | -10,733 | 54.44 USD | $584.3K | SEC |
| Mar 12, 2025 | Sell | -42,930 | 54.44 USD | $2.3M | SEC |
| Mar 12, 2025 | Sell | -136 | 55.01 USD | $7.5K | SEC |
| Mar 12, 2025 | Sell | -211 | 55.01 USD | $11.6K | SEC |
| Mar 12, 2025 | Sell | -603 | 55.05 USD | $33.2K | SEC |
| Mar 12, 2025 | Sell | -14,267 | 54.01 USD | $770.6K | SEC |
| Mar 12, 2025 | Sell | -68,766 | 54.29 USD | $3.7M | SEC |
| Mar 12, 2025 | Sell | -233 | 55.05 USD | $12.8K | SEC |
| Mar 12, 2025 | Sell | -26,596 | 54.29 USD | $1.4M | SEC |
| Mar 12, 2025 | Sell | -933 | 55.05 USD | $51.4K | SEC |